Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

187 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Identification of BDNF sensitive electrophysiological markers of synaptic activity and their structural correlates in healthy subjects using a genetic approach utilizing the functional BDNF Val66Met polymorphism.
Soltész F, Suckling J, Lawrence P, Tait R, Ooi C, Bentley G, Dodds CM, Miller SR, Wille DR, Byrne M, McHugh SM, Bellgrove MA, Croft RJ, Lu B, Bullmore ET, Nathan PJ. Soltész F, et al. Among authors: nathan pj. PLoS One. 2014 Apr 23;9(4):e95558. doi: 10.1371/journal.pone.0095558. eCollection 2014. PLoS One. 2014. PMID: 24760076 Free PMC article.
Effects of the BDNF Val66Met polymorphism and met allele load on declarative memory related neural networks.
Dodds CM, Henson RN, Suckling J, Miskowiak KW, Ooi C, Tait R, Soltesz F, Lawrence P, Bentley G, Maltby K, Skeggs A, Miller SR, McHugh S, Bullmore ET, Nathan PJ. Dodds CM, et al. Among authors: nathan pj. PLoS One. 2013 Nov 11;8(11):e74133. doi: 10.1371/journal.pone.0074133. eCollection 2013. PLoS One. 2013. PMID: 24244264 Free PMC article. Clinical Trial.
Structural neuroimaging correlates of allelic variation of the BDNF val66met polymorphism.
Forde NJ, Ronan L, Suckling J, Scanlon C, Neary S, Holleran L, Leemans A, Tait R, Rua C, Fletcher PC, Jeurissen B, Dodds CM, Miller SR, Bullmore ET, McDonald C, Nathan PJ, Cannon DM. Forde NJ, et al. Among authors: nathan pj. Neuroimage. 2014 Apr 15;90:280-9. doi: 10.1016/j.neuroimage.2013.12.050. Epub 2013 Dec 31. Neuroimage. 2014. PMID: 24384148 Free article.
The potent M1 receptor allosteric agonist GSK1034702 improves episodic memory in humans in the nicotine abstinence model of cognitive dysfunction.
Nathan PJ, Watson J, Lund J, Davies CH, Peters G, Dodds CM, Swirski B, Lawrence P, Bentley GD, O'Neill BV, Robertson J, Watson S, Jones GA, Maruff P, Croft RJ, Laruelle M, Bullmore ET. Nathan PJ, et al. Int J Neuropsychopharmacol. 2013 May;16(4):721-31. doi: 10.1017/S1461145712000752. Epub 2012 Aug 29. Int J Neuropsychopharmacol. 2013. PMID: 22932339 Free article. Clinical Trial.
A randomized, double-blind, placebo-controlled, 16-week study of the H3 receptor antagonist, GSK239512 as a monotherapy in subjects with mild-to-moderate Alzheimer's disease.
Grove RA, Harrington CM, Mahler A, Beresford I, Maruff P, Lowy MT, Nicholls AP, Boardley RL, Berges AC, Nathan PJ, Horrigan JP. Grove RA, et al. Among authors: nathan pj. Curr Alzheimer Res. 2014 Jan;11(1):47-58. doi: 10.2174/1567205010666131212110148. Curr Alzheimer Res. 2014. PMID: 24359500 Clinical Trial.
187 results